S
Santhera Pharmaceuticals Holding AG
SIX:SANN
Santhera Pharmaceuticals Holding AG
SIX:SANN
Price:
9.25 CHF
-0.96%
Market Closed
Updated:
May 21, 2024
Santhera Pharmaceuticals Holding AG
Gross Profit
|
Santhera Pharmaceuticals Holding AG
Gross Profit Peer Comparison
Comparables:
ADCT
CRSP
BSLN
IDIA
KURN
Competitive Gross Profit Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Gross Profit | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
S
|
Santhera Pharmaceuticals Holding AG
SIX:SANN
|
Gross Profit
CHf100.1m
|
CAGR 3-Years
180%
|
CAGR 5-Years
30%
|
CAGR 10-Years
N/A
|
|
|
ADC Therapeutics SA
NYSE:ADCT
|
Gross Profit
$67m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
CRISPR Therapeutics AG
NASDAQ:CRSP
|
Gross Profit
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Basilea Pharmaceutica AG
SIX:BSLN
|
Gross Profit
CHf130.8m
|
CAGR 3-Years
8%
|
CAGR 5-Years
3%
|
CAGR 10-Years
12%
|
|
|
Idorsia Ltd
SIX:IDIA
|
Gross Profit
CHf90.8m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Kuros Biosciences AG
SIX:KURN
|
Gross Profit
CHf28.5m
|
CAGR 3-Years
157%
|
CAGR 5-Years
115%
|
CAGR 10-Years
N/A
|
See Also
What is Santhera Pharmaceuticals Holding AG's Gross Profit?
Gross Profit
100.1m
CHF
100.1m
CHF
Based on the financial report for Dec 31, 2023, Santhera Pharmaceuticals Holding AG's Gross Profit amounts to 100.1m CHF.
What is Santhera Pharmaceuticals Holding AG's Gross Profit growth rate?
Gross Profit CAGR 5Y
30%
30%
Over the last year, the Gross Profit growth was 2 480%. The average annual Gross Profit growth rates for Santhera Pharmaceuticals Holding AG have been 180% over the past three years , 30% over the past five years .
You don't have any saved screeners yet
